Streetbeat News

Products Services

META

Meta Platforms Inc. (NASDAQ:META) is urging Oculus users to migrate their accounts to Meta before the March 29 deadline to avoid losing access to content. This move is part of Meta's rebranding efforts from Facebook and aims to streamline user experience by transitioning Oculus Quest to Meta Quest VR headsets. The account migration, introduced in June 2022, allows users to use an alternative login method without needing a Facebook account.

Portfolio Pulse from Franca Quarneti

March 05, 2024 | 8:31 pm

BAX

DVA

FMS

NVO

Dialysis provider stocks DaVita Inc (DVA), Fresenius Medical Care AG (FMS), and Baxter International Inc (BAX) traded higher after Novo Nordisk A/S (NVO) announced successful trial results for semaglutide, easing concerns over its impact on the kidney care market. Despite initial fears, the 24% reduction in kidney disease progression and related deaths was at the lower end of expectations, leading to a relief rally in the shares of these companies.

Portfolio Pulse from Vandana Singh

March 05, 2024 | 8:21 pm

AMZN

TGT

WMT

Target (NYSE:TGT) reported better-than-expected holiday quarter results, with revenue and net income surpassing estimates. Shares surged 12% as Target announced a paid membership program to compete with Amazon (NASDAQ:AMZN) and Walmart (NYSE:WMT). The program, launching next month, aims to offer same-day delivery and other benefits for $49 per year. Despite a challenging year with sluggish sales and increased theft, Target is optimistic about its sales recovery through new initiatives.

Portfolio Pulse from Upwallstreet

March 05, 2024 | 8:15 pm

JNJ

Johnson & Johnson announced a mistrial in the Sugarman case, reaffirming the safety of its Johnson's Baby Powder. The company stated the product does not contain asbestos and does not cause cancer.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 8:04 pm

AAPL

Major stock indexes experienced a decline, primarily due to a downturn in technology stocks. This was notably influenced by a decrease in Apple's iPhone sales in China, leading to a fall in Apple shares.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 8:02 pm

GreenPower Motor Company Inc. (NASDAQ: GP) delivered the first all-electric Type D BEAST school bus to Phoenix Elementary School District in Arizona, marking the state's first deployment of GreenPower's zero-emission vehicle. The BEAST is designed with a unified structure featuring an aluminum body and a high strength steel chassis, offering dual port charging with Level 2 and DC Fast Charging options. Phoenix Elementary School District, serving around 5,000 students, aims to transition to all-electric student transportation for safer and more sustainable options. The district purchased the BEAST through GreenPower's authorized dealer RWC Group.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 8:02 pm

BNBUSD

BTCUSD

COIN

Bitcoin (BTC) has reached a new all-time high, sparking interest among potential investors. This guide provides steps for purchasing Bitcoin safely, emphasizing the importance of choosing a reputable and regulated cryptocurrency exchange. Key considerations include the exchange's reputation, supported payment methods, fees, and ease of use. Coinbase (NASDAQ:COIN), Gemini, Kraken, and Binance (CRYPTO: BNB) are highlighted as popular options. The guide also covers the buying process, secure storage of Bitcoin, and the importance of managing investments cautiously due to the market's volatility.

Portfolio Pulse from Murtuza Merchant

March 05, 2024 | 8:01 pm

AAPL

MTCH

At the Morgan Stanley Tech Conference, Match Group's CFO highlighted the impact of Apple's App Store fees on the company's margins, emphasizing that the 30% fee could be better invested in innovation rather than going to Apple.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 8:01 pm

ENVB

Enveric Biosciences Canada, a subsidiary of Enveric Biosciences (ENVB), has been awarded U.S. Patent #11918594 for multi-substituent psilocybin derivatives and their usage methods. This patent represents a significant advancement in the development of psychedelic-based therapeutics, potentially positioning ENVB at the forefront of this emerging field.

Portfolio Pulse from Charles Gross

March 05, 2024 | 7:58 pm

ALNY

RHHBY

Alnylam Pharmaceuticals Inc (ALNY) and Roche Holdings AG (RHHBY) announced positive results from the KARDIA-2 Phase 2 study of zilebesiran for hypertension, meeting its primary endpoint. Zilebesiran, an RNAi therapeutic, showed significant reductions in systolic blood pressure across three patient cohorts. The drug is co-developed with Roche and demonstrates a promising safety profile. A global Phase 2 study, KARDIA-3, is also underway. Despite the focus on the HELIOS-B trial for vutrisiran, analysts maintain an optimistic outlook on Alnylam, particularly for its TTR silencers, with an Outperform rating reaffirmed. ALNY shares dropped 1.22% to $148.21.

Portfolio Pulse from Vandana Singh

March 05, 2024 | 7:38 pm